Methadone Hydrochloride Alkaloid-Int (Methadone Hydrochloride)

Methadone acts as a full agonist at the μ‑opioid receptor, providing analgesia and reducing withdrawal symptoms. It also blocks NMDA receptors and inhibits serotonin and norepinephrine reuptake, which contributes to its effectiveness in both pain control and opioid substitution.

The appropriate dose of methadone hydrochloride is determined individually by the prescribing clinician based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosage adjustments are made according to therapeutic goals and safety monitoring.

Methadone is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out. It may be used when the benefits outweigh potential risks, and dosing should be closely monitored. Methadone does pass into breast milk, so breastfeeding decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methadone offers a long half‑life and strong μ‑opioid receptor activity, allowing once‑daily dosing for many patients. Compared with buprenorphine, methadone has a higher risk of respiratory depression but may provide more robust suppression of cravings for individuals with high opioid tolerance.

Methadone Hydrochloride Alkaloid-Int should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency.

The medication is administered orally, typically as a tablet or solution, and should be taken exactly as prescribed. Patients should swallow tablets whole with water and avoid crushing or chewing unless specifically instructed by a healthcare provider.

The most serious risks include respiratory depression, especially during dose escalation or when combined with other CNS depressants, and cardiac arrhythmias due to QT interval prolongation. Regular monitoring of respiratory function and ECG is essential to mitigate these hazards.

Methadone is contraindicated in patients with known hypersensitivity to methadone, those taking monoamine oxidase inhibitors, and individuals with severe respiratory insufficiency or uncontrolled cardiac arrhythmias. Caution is also advised for patients with significant hepatic impairment.